Vendor, Aurora, CO
Gelsana Therapeutics Inc.
UEI CPRMRH9NFTF5, CAGE 97R25
1 award and $1,249,624 obligated between March 7, 2024 and December 3, 2025, 100% under full and open competition, against 198.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $1,249,624 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Purchase Order | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| FA864924P0508Purchase Order, March 7, 2024, Full and Open Competition After Exclusion of Sources, 198 offers | FA8649 USAF SBIR STTR Cntrctng AFRLDepartment of the Air Force | Advancing Military Healthcare: Novel Zwitterionic Hydrogels for Enhanced Wound Healing in Combat-Related Burn InjuriesNAICS 541715, PSC AC32 | $1,249,624 |
- Places of performance
- Colorado
- Product and service codes
- AC32 National Defense R&D Services; Defense-Related Activities; Applied Research
- Transactions
- 5 across 1 awards